RealWorld Dynamix™: Biologic Switching Patterns in IBD Patient Power in Action

Spherix Global Insights collaborated with 211 practicing gastroenterologists in the US to analyze the medical records for over 1,000 patients with IBD who had recently been switched from one biologic to another. Patients are playing an increasing role in treatment decisions.

About Spherix Global Insights
Spherix Global Insights is a newly established business intelligence and market research company headquartered in Cambridge, MA with EU offices in Zug, Switzerland. We specialize in renal, autoimmune, neurologic and rare disease markets.

For more information contact:
Telephone: (800) 661-0571
Email: [email protected]
www.spherixglobalinsights.com